This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ASM journals
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Igwe, E. I.
Right arrow Articles by Heesemann, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Igwe, E. I.
Right arrow Articles by Heesemann, J.

 Previous Article  |  Next Article 

Infection and Immunity, October 1999, p. 5500-5507, Vol. 67, No. 10
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Rational Live Oral Carrier Vaccine Design by Mutating Virulence-Associated Genes of Yersinia enterocolitica

Emeka I. Igwe, Holger Rüssmann, Andreas Roggenkamp, Annette Noll, Ingo B. Autenrieth, and J. Heesemann*

Max von Pettenkofer Institute for Hygiene and Medical Microbiology, Ludwig Maximilians University Munich, 80336 Munich, Germany

Received 10 May 1999/Returned for modification 5 July 1999/Accepted 21 July 1999

Three different Yersinia enterocolitica serotype O8 strains harboring mutations in virulence-associated genes coding for Yersinia adhesin A (YadA), Mn-cofactored superoxide dismutase (SodA), and high-molecular-weight protein 1 were analyzed for their ability to colonize and persist in tissues after orogastric immunization of C57BL/6 mice. We demonstrated that all three Yersinia mutant strains were markedly impaired in their ability to disseminate into the spleens and livers of immunized mice but were able to colonize the Peyer's patches for at least 12 days, resulting in the induction of significant antibody titers against Yersinia outer proteins (Yops) and in the priming of Yersinia antigen-specific CD4+ Th1 cells isolated from spleens. The high level of attenuation did not diminish the immunogenic properties of the mutant strains. In fact, mice immunized with a single oral dose of any of the mutant strains were protected against a lethal oral-challenge infection with wild-type Y. enterocolitica. Moreover, adoptive transfer of Yersinia-specific antibodies from sera of mice immunized with the mutant WAP-314 sodA revealed that this protection could be mediated by Yersinia-specific immunoglobulins.


* Corresponding author. Mailing address: Max von Pettenkofer Institute for Hygiene and Medical Microbiology, Ludwig Maximilians University Munich, Pettenkoferstr. 9a, 80336 Munich, Germany. Phone: 49-89-51605200. Fax: 49-89-51605202. E-mail: ruessmann{at}m3401.mpk.med.uni-muenchen.de.


Infection and Immunity, October 1999, p. 5500-5507, Vol. 67, No. 10
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Trulzsch, K., Geginat, G., Sporleder, T., Ruckdeschel, K., Hoffmann, R., Heesemann, J., Russmann, H. (2005). Yersinia Outer Protein P Inhibits CD8 T Cell Priming in the Mouse Infection Model. J. Immunol. 174: 4244-4251 [Abstract] [Full Text]  
  • Gundel, I., Weidinger, G., ter Meulen, V., Heesemann, J., Russmann, H., Niewiesk, S. (2003). Oral immunization with recombinant Yersinia enterocolitica expressing a measles virus CD4 T cell epitope protects against measles virus-induced encephalitis. J. Gen. Virol. 84: 775-779 [Abstract] [Full Text]  
  • Di Genaro, M. S., Waidmann, M., Kramer, U., Hitziger, N., Bohn, E., Autenrieth, I. B. (2003). Attenuated Yersiniaenterocolitica Mutant Strains Exhibit Differential Virulence in Cytokine-Deficient Mice: Implications for the Development of Novel Live Carrier Vaccines. Infect. Immun. 71: 1804-1812 [Abstract] [Full Text]  
  • Kramer, U., Rizos, K., Apfel, H., Autenrieth, I. B., Lattemann, C. T. (2003). Autodisplay: Development of an Efficacious System for Surface Display of Antigenic Determinants in Salmonella Vaccine Strains. Infect. Immun. 71: 1944-1952 [Abstract] [Full Text]  
  • Al-Mariri, A., Tibor, A., Lestrate, P., Mertens, P., De Bolle, X., Letesson, J.-J. (2002). Yersinia enterocolitica as a Vehicle for a Naked DNA Vaccine Encoding Brucella abortus Bacterioferritin or P39 Antigen. Infect. Immun. 70: 1915-1923 [Abstract] [Full Text]  
  • EDWARDS, K. M., CYNAMON, M. H., VOLADRI, R. K. R., HAGER, C. C., DESTEFANO, M. S., THAM, K. T., LAKEY, D. L., BOCHAN, M. R., KERNODLE, D. S. (2001). Iron-cofactored Superoxide Dismutase Inhibits Host Responses to Mycobacterium tuberculosis. Am. J. Respir. Crit. Care Med. 164: 2213-2219 [Abstract] [Full Text]